老年重症心力衰竭急诊内科治疗的效果分析

Analysis of the Effect of Emergency Medical Treatment for Elderly Patients with Severe Heart Failure

目的探究急诊内科疗法对老年重症心力衰竭患者的临床疗效。方法研究于2016年1月—2017年5月期间收集老年重症心力衰竭患者82例平均分组行常规治疗,及联合应用厄贝沙坦氢氯噻嗪以及美托洛尔治疗。比较两组患者临床疗效、心脏功能改善情况及死亡率。结果治疗前对照组与观察组患者BNP水平(989.36±32.44)、(986.73±30.25)ng/L及LVEF水平(30.16±2.79)%、(30.25±2.81)%相比较差异无统计学意义(t=0.379 7,0.145 5,P>0.05);治疗后观察组BNP水平(246.71±20.33)ng/L及死亡率2.44%显著低于对照组(900.17±21.38)ng/L及14.63%,数据差异有统计学意义(t=141.823 5,χ~2=4.904 8,P<0.05),而LVEF水平(46.42±6.11)%及临床疗效92.68%则明显高于对照组(38.49±6.05)%及75.61%,数据差异有统计学意义(t=5.905 3,χ~2=4.479 4,P<0.05)。结论急诊内科疗法对老年重症心力衰竭患者具有良好的治疗效果,因此该种治疗方案值得在临床中进行推广。

Objective To investigate the clinical efficacy of emergency medical treatment in elderly patients with severe heart failure. Methods A total of 82 patients with severe heart failure in the elderly were enrolled between January 2016 and May 2017. The patients were treated with erbartan hydrochlorothiazide and metoprolol. The clinical efficacy, improvement of cardiac function and mortality were compared between the two groups. Results There was no statistical comparison between BNP levels (989.36±32.44),(986.73±30.25) ng/L, and LVEF levels (30.16±2.79)% and (30.25±2.81)% in the control group and the observation group. Significance (t=0.379 7,0.145 5,P>0.05); after treatment, the BNP level (246.71±20.33) ng/L and the mortality rate of 2.44% were significantly lower than the control group (900.17±21.38) ng/L and 14.63%, with statistical significance (t=141.823 5,χ^2=4.904 8, P<0.05), while LVEF level (46.42±6.11)% and clinical efficacy 92.68% were significantly higher than the control group (38.49±6.05)% and 75.61%, with statistical significance (t=5.905 3,χ^2=4.479 4, P<0.05). Conclusion Emergency medical therapy has a good therapeutic effect on elderly patients with severe heart failure. Therefore, this treatment plan is worthy of promotion in the clinic.